Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nextgen Healthcare, Inc. (QSII) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nextgen Healthcare, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 708818.
Total stock buying since 2014: $1,204,043.
Total stock sales since 2014: $11,664,324.
Total stock option exercises since 2014: $3,980,825.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 0 | $0 | 42,569 | $0 |
| 2022 | 0 | $0 | 290,560 | $5,786,461 | 454,965 | $3,852,075 |
| 2021 | 14,500 | $227,517 | 119,897 | $2,277,764 | 7,750 | $128,750 |
| 2020 | 15,575 | $143,476 | 83,151 | $1,435,409 | 0 | $0 |
| 2019 | 0 | $0 | 95,773 | $1,834,388 | 0 | $0 |
| 2018 | 40,000 | $524,000 | 0 | $0 | 0 | $0 |
| 2017 | 0 | $0 | 20,968 | $330,302 | 0 | $0 |
| 2016 | 18,300 | $223,766 | 0 | $0 | 0 | $0 |
| 2015 | 2,500 | $38,625 | 0 | $0 | 0 | $0 |
| 2014 | 3,050 | $46,659 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 0 | $0 | 0 | $0 | 42,569 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 137,772 | $0 |
| 2022-11 | 0 | $0 | 97,116 | $1,942,416 | 97,116 | $1,372,734 |
| 2022-10 | 0 | $0 | 32,372 | $654,173 | 32,372 | $459,682 |
| 2022-09 | 0 | $0 | 3,500 | $60,430 | 50,154 | $0 |
| 2022-08 | 0 | $0 | 3,500 | $60,718 | 0 | $0 |
| 2022-07 | 0 | $0 | 3,500 | $60,872 | 0 | $0 |
| 2022-06 | 0 | $0 | 3,500 | $63,581 | 0 | $0 |
| 2022-05 | 0 | $0 | 37,338 | $743,348 | 33,838 | $478,300 |
| 2022-04 | 0 | $0 | 37,338 | $755,051 | 33,838 | $480,499 |
| 2022-03 | 0 | $0 | 69,875 | $1,397,696 | 69,875 | $1,060,860 |
| 2022-02 | 0 | $0 | 2,521 | $48,176 | 0 | $0 |
| 2021-12 | 3,000 | $48,690 | 0 | $0 | 0 | $0 |
| 2021-11 | 11,500 | $178,827 | 12,349 | $205,802 | 0 | $0 |
| 2021-08 | 0 | $0 | 9,000 | $145,224 | 0 | $0 |
| 2021-06 | 0 | $0 | 5,102 | $87,188 | 0 | $0 |
| 2021-04 | 0 | $0 | 9,000 | $168,344 | 0 | $0 |
| 2021-03 | 0 | $0 | 25,000 | $474,850 | 0 | $0 |
| 2021-02 | 0 | $0 | 59,446 | $1,196,356 | 7,750 | $128,750 |
| 2020-12 | 0 | $0 | 70,000 | $1,242,756 | 0 | $0 |
| 2020-08 | 0 | $0 | 13,151 | $192,653 | 0 | $0 |
| 2020-03 | 15,575 | $143,476 | 0 | $0 | 0 | $0 |
| 2019-06 | 0 | $0 | 95,773 | $1,834,388 | 0 | $0 |
| 2018-03 | 40,000 | $524,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-22 | Waters Mitchell (EVP, Commercial Growth) | Option Ex | 5,452 | .00 | 0 |
| 2023-09-22 | Sides David William (President and CEO) | Option Ex | 24,333 | .00 | 0 |
| 2023-09-22 | Arnold James Robert Jr. (Chief Financial Officer) | Option Ex | 9,400 | .00 | 0 |
| 2023-09-22 | Linton Jeffrey D (EVP, General Counsel/Secretary) | Option Ex | 3,384 | .00 | 0 |
| 2022-12-27 | Greene Donna Cullen (EVP, Human Resources) | Option Ex | 15,054 | .00 | 0 |
| 2022-12-27 | Metcalfe David A (Chief Technology Officer) | Option Ex | 42,215 | .00 | 0 |
| 2022-12-27 | Arnold James Robert Jr. (Chief Financial Officer) | Option Ex | 54,978 | .00 | 0 |
| 2022-12-27 | Linton Jeffrey D (EVP, General Counsel/Secretary) | Option Ex | 25,525 | .00 | 0 |
| 2022-11-01 | Metcalfe David A (Chief Technology Officer) | Sale | 64,744 | 20.00 | 1,294,944 |
| 2022-11-01 | Metcalfe David A (Chief Technology Officer) | Option Ex | 64,744 | 14.13 | 915,156 |
| 2022-10-26 | Metcalfe David A (Chief Technology Officer) | Sale | 32,372 | 20.21 | 654,173 |
| 2022-10-26 | Metcalfe David A (Chief Technology Officer) | Option Ex | 32,372 | 14.20 | 459,682 |
| 2022-09-22 | Greene Donna Cullen (EVP, Human Resources) | Option Ex | 2,256 | .00 | 0 |
| 2022-09-22 | Waters Mitchell (EVP, Commercial Growth) | Option Ex | 5,452 | .00 | 0 |
| 2022-09-22 | Metcalfe David A (Chief Technology Officer) | Option Ex | 5,328 | .00 | 0 |
| 2022-09-22 | Sides David William (President and CEO) | Option Ex | 24,334 | .00 | 0 |
| 2022-09-22 | Arnold James Robert Jr. (Chief Financial Officer) | Option Ex | 9,400 | .00 | 0 |
| 2022-09-22 | Linton Jeffrey D (EVP, General Counsel/Secretary) | Option Ex | 3,384 | .00 | 0 |
| 2022-09-01 | Barbarosh Craig A. (Director) | Sale | 3,500 | 17.27 | 60,430 |
| 2022-08-01 | Barbarosh Craig A. (Director) | Sale | 3,500 | 17.35 | 60,718 |
| 2022-07-01 | Barbarosh Craig A. (Director) | Sale | 3,500 | 17.39 | 60,872 |
| 2022-06-01 | Barbarosh Craig A. (Director) | Sale | 3,500 | 18.17 | 63,581 |
| 2022-05-03 | Metcalfe David A (Chief Technology Officer) | Sale | 33,838 | 20.00 | 676,827 |
| 2022-05-03 | Metcalfe David A (Chief Technology Officer) | Option Ex | 33,838 | 14.13 | 478,300 |
| 2022-05-02 | Barbarosh Craig A. (Director) | Sale | 3,500 | 19.01 | 66,521 |
| 2022-04-25 | Metcalfe David A (Chief Technology Officer) | Sale | 33,838 | 20.11 | 680,617 |
| 2022-04-25 | Metcalfe David A (Chief Technology Officer) | Option Ex | 33,838 | 14.20 | 480,499 |
| 2022-04-01 | Barbarosh Craig A. (Director) | Sale | 3,500 | 21.27 | 74,434 |
| 2022-03-15 | Ahmadzai David (Chief Accounting Officer) | Sale | 6,250 | 19.55 | 122,206 |
| 2022-03-15 | Ahmadzai David (Chief Accounting Officer) | Option Ex | 6,250 | 16.60 | 103,750 |
| 2022-03-03 | Greene Donna Cullen (EVP, Human Resources) | Sale | 63,625 | 20.05 | 1,275,490 |
| 2022-03-03 | Greene Donna Cullen (EVP, Human Resources) | Option Ex | 63,625 | 15.04 | 957,110 |
| 2022-02-02 | Waters Mitchell (EVP, Commercial Growth) | Sale | 2,521 | 19.11 | 48,176 |
| 2021-12-10 | Velamoor Srinivas S (Chief Growth & Strategy Office) | Buy | 3,000 | 16.23 | 48,690 |
| 2021-11-30 | Sides David William (President and CEO) | Buy | 6,500 | 15.62 | 101,497 |
| 2021-11-30 | Arnold James Robert Jr. (Chief Financial Officer) | Buy | 5,000 | 15.47 | 77,330 |
| 2021-11-03 | Waters Mitchell (EVP, Commercial Growth) | Sale | 3,349 | 17.00 | 56,933 |
| 2021-11-02 | Barbarosh Craig A. (Director) | Sale | 9,000 | 16.54 | 148,869 |
| 2021-08-03 | Barbarosh Craig A. (Director) | Sale | 9,000 | 16.14 | 145,224 |
| 2021-06-03 | Waters Mitchell (EVP, Commercial Growth) | Sale | 5,102 | 17.09 | 87,188 |
| 2021-04-12 | Barbarosh Craig A. (Director) | Sale | 9,000 | 18.70 | 168,344 |
| 2021-03-22 | Frantz John R (CEO and President) | Sale | 25,000 | 18.99 | 474,850 |
| 2021-02-09 | Rosenzweig Lance (Director) | Sale | 12,000 | 20.82 | 249,900 |
| 2021-02-08 | Rosenzweig Lance (Director) | Sale | 12,000 | 20.52 | 246,240 |
| 2021-02-04 | Frantz John R (CEO and President) | Sale | 25,000 | 19.81 | 495,350 |
| 2021-02-03 | Ahmadzai David (Chief Accounting Officer) | Sale | 10,446 | 19.61 | 204,866 |
| 2021-02-03 | Ahmadzai David (Chief Accounting Officer) | Option Ex | 7,750 | 16.61 | 128,750 |
| 2020-12-21 | Frantz John R (CEO and President) | Sale | 50,000 | 17.85 | 892,650 |
| 2020-12-04 | Bristol George H (Director) | Sale | 15,200 | 17.50 | 266,015 |
| 2020-12-03 | Bristol George H (Director) | Sale | 4,800 | 17.52 | 84,091 |
| 2020-08-12 | Rosenzweig Lance (Director) | Sale | 1,764 | 14.54 | 25,646 |
| 2020-08-11 | Rosenzweig Lance (Director) | Sale | 5,687 | 14.60 | 83,041 |
| 2020-08-10 | Rosenzweig Lance (Director) | Sale | 5,700 | 14.73 | 83,966 |
| 2020-03-13 | Arnold James Robert Jr. (Chief Financial Officer) | Buy | 5,000 | 9.20 | 46,000 |
| 2020-03-13 | Linton Jeffrey D (EVP, General Counsel/Secretary) | Buy | 575 | 8.48 | 4,876 |
| 2020-03-12 | Margolis Jeffrey H (Director) | Buy | 10,000 | 9.26 | 92,600 |
| 2019-06-14 | Razin Sheldon (Director) | Sale | 21,900 | 19.07 | 417,633 |
| 2019-06-13 | Razin Sheldon (Director) | Sale | 4,018 | 19.06 | 76,583 |
| 2019-06-07 | Razin Sheldon (Director) | Sale | 22,568 | 19.10 | 431,048 |
| 2019-06-06 | Razin Sheldon (Director) | Sale | 1,113 | 19.03 | 21,180 |
| 2019-06-04 | Razin Sheldon (Director) | Sale | 32,301 | 19.23 | 620,986 |
| 2019-06-03 | Bristol George H (Director) | Sale | 13,873 | 19.24 | 266,958 |
| 2018-03-15 | Arnold James Robert Jr. (Chief Financial Officer) | Buy | 40,000 | 13.10 | 524,000 |
| 2017-08-18 | Pflueger Russell | Sale | 17,568 | 15.73 | 276,344 |
| 2017-08-17 | Pflueger Russell | Sale | 3,400 | 15.87 | 53,958 |
| 2016-06-14 | Arnold James Robert Jr. (Chief Financial Officer) | Buy | 8,300 | 12.02 | 99,766 |
| 2016-06-13 | Margolis Jeffrey H | Buy | 10,000 | 12.40 | 124,000 |
| 2015-12-09 | Frantz John R (CEO and President) | Buy | 2,500 | 15.45 | 38,625 |
| 2014-07-30 | Leavitt Jocelyn (EVP, General Counsel/Secretary) | Buy | 1,450 | 15.23 | 22,083 |
| 2014-07-29 | Leavitt Jocelyn (EVP, General Counsel/Secretary) | Buy | 1,600 | 15.36 | 24,576 |
Insider trading activities including stock purchases, stock sales, and option exercises of QSII listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nextgen Healthcare, Inc. (symbol QSII, CIK number 708818) see the Securities and Exchange Commission (SEC) website.